WEST PHARMACEUTICAL SERVICES INC

The proposal requests that the Board adopt a formal policy requiring the roles of Chair of the Board and Chief Executive Officer to be held by separate individuals and that the Board Chair be an independent director. It also permits the Board to appoint a non-independent interim chair while an independent chair is sought, and suggests phasing in the policy around the next CEO contract renewal or transition. The proponent argues the change would strengthen oversight, reduce conflicts of interest, increase transparency and enhance accountability to shareholders. The proposal asks shareholders to approve adoption of the independent-chair policy.